Literature DB >> 12825833

Epibatidine: impact on nicotinic receptor research.

Małgorzata Dukat1, Richard A Glennon.   

Abstract

Epibatidine is a natural product that was isolated and identified by Daly and coworkers in 1992. Since that time, it has had a profound influence on the investigation of alpha4beta2 nicotinic cholinergic (nACh) receptor pharmacophore models, and has inspired the development of novel agents with therapeutic potential in CNS disorders. Apart from acetylcholine and nicotine, probably no other agent has had as much recent impact on nACh research as has epibatidine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12825833     DOI: 10.1023/a:1023692705700

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  40 in total

Review 1.  The pharmacological basis of contemporary pain management.

Authors:  R D MacPherson
Journal:  Pharmacol Ther       Date:  2000-11       Impact factor: 12.310

Review 2.  Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics.

Authors:  M W Decker; M D Meyer
Journal:  Biochem Pharmacol       Date:  1999-09-15       Impact factor: 5.858

3.  Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues.

Authors:  F I Carroll; F Liang; H A Navarro; L E Brieaddy; P Abraham; M I Damaj; B R Martin
Journal:  J Med Chem       Date:  2001-06-21       Impact factor: 7.446

Review 4.  Nicotinic acetylcholine receptors and imaging.

Authors:  D Gündisch
Journal:  Curr Pharm Des       Date:  2000-07       Impact factor: 3.116

5.  Improving the nicotinic pharmacophore with a series of (Isoxazole)methylene-1-azacyclic compounds: synthesis, structure-activity relationship, and molecular modeling.

Authors:  J E Tønder; J B Hansen; M Begtrup; I Pettersson; K Rimvall; B Christensen; U Ehrbar; P H Olesen
Journal:  J Med Chem       Date:  1999-12-02       Impact factor: 7.446

6.  2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling.

Authors:  A O Koren; A G Horti; A G Mukhin; D Gündisch; A S Kimes; R F Dannals; E D London
Journal:  J Med Chem       Date:  1998-09-10       Impact factor: 7.446

7.  Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist.

Authors:  F I Carroll; J R Lee; H A Navarro; L E Brieaddy; P Abraham; M I Damaj; B R Martin
Journal:  J Med Chem       Date:  2001-11-22       Impact factor: 7.446

8.  Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity.

Authors:  P E Molina; Y S Ding; F I Carroll; F Liang; N D Volkow; N Pappas; M Kuhar; N Abumrad; S J Gatley; J S Fowler
Journal:  Nucl Med Biol       Date:  1997-11       Impact factor: 2.408

9.  Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.

Authors:  Christopher G V Sharples; Gunter Karig; Graham L Simpson; James A Spencer; Emma Wright; Neil S Millar; Susan Wonnacott; Timothy Gallagher
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

10.  Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes.

Authors:  Jie Cheng; Chunming Zhang; Edwin D Stevens; Sari Izenwasser; Dean Wade; Shaoyi Chen; Dennis Paul; Mark L Trudell
Journal:  J Med Chem       Date:  2002-07-04       Impact factor: 7.446

View more
  7 in total

1.  Phantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyi.

Authors:  Richard W Fitch; Thomas F Spande; H Martin Garraffo; Herman J C Yeh; John W Daly
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

2.  Intrathecal injection of an alpha seven nicotinic acetylcholine receptor agonist attenuates gp120-induced mechanical allodynia and spinal pro-inflammatory cytokine profiles in rats.

Authors:  Lisa C Loram; Jacqueline A Harrison; Lindsey Chao; Frederick R Taylor; Anireddy Reddy; Carissa L Travis; Rona Giffard; Yousef Al-Abed; Kevin Tracey; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2010-03-28       Impact factor: 7.217

3.  Involvement of Nicotinic Receptor Subtypes in the Behavioral Effects of Nicotinic Drugs in Squirrel Monkeys.

Authors:  Sarah L Withey; Michelle R Doyle; Jack Bergman; Rajeev I Desai
Journal:  J Pharmacol Exp Ther       Date:  2018-05-21       Impact factor: 4.030

4.  Interacting amino acid replacements allow poison frogs to evolve epibatidine resistance.

Authors:  Rebecca D Tarvin; Cecilia M Borghese; Wiebke Sachs; Juan C Santos; Ying Lu; Lauren A O'Connell; David C Cannatella; R Adron Harris; Harold H Zakon
Journal:  Science       Date:  2017-09-22       Impact factor: 47.728

Review 5.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

6.  The 7-aza-norbornane nucleus of epibatidine: 7-aza-bicyclo-[2.2.1]heptan-7-ium chloride.

Authors:  Sergey N Britvin; Andrey M Rumyantsev
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-08-30

7.  The discriminative stimulus effects of epibatidine in C57BL/6J mice.

Authors:  Fernando B de Moura; Takato Hiranita; Lance R McMahon
Journal:  Behav Pharmacol       Date:  2020-09       Impact factor: 2.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.